The German company said booming artificial-intelligence demand would help its electronics sales grow faster than previously ...

Merck KGaA lowered its medium-term outlook for its healthcare and life-science segment due to China challenges and recent ...

On September 12, Jason Draho, UBS Global Wealth Management ... beating its benchmark by 150 percentage points (see more ...

Jason Kelce is having a fun retirement — and seemingly turning heads while hanging with fans. The longtime Eagles center was spotted relaxing shirtless on a beach — geotagged in New Jersey ...

Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest ...

Stephanie Beatty for Minted Former Philadelphia Eagles center Jason Kelce is all about spending quality time with his family. Jason, who announced his retirement from the NFL in March 2024 ...

Kineta, Inc. (OTC Pink: KANT) , a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that its ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

“The use of the PET ligand for better understanding the disease process itself will be very valuable,” says Jason Uslaner, VP, Research Science at Merck. “What levels of alpha-synuclein and ...

Jason Zemansky’s rating is based on a nuanced analysis of ... Market dominance by competitors like Merck and recent clinical disappointments have raised questions about dom’s potential to be a profit ...

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care ...

EXEL is set to evaluate investigational zanzalintinib in combination with Merck;s Keytruda (pembrolizumab) and Welireg in head and neck cancer and renal cell carcinoma, respectively. ALAMEDA ...